Saturday, December 11, 2021 3:51:20 PM
Thank you Umibe, I believe the moderators should sticky this post.
There were several other great posts in the last day, one mentioned the possible roll of the MM's in yesterday's trading. I would suspect that the MM's are shaking the trees by selling to drop the price, then swooping in and buying far more shares than they sold for cheap. Why such a behavior, because they're anticipating good news and most important, they know they'll have great demand from some of their Institutional customers beginning January 3rd, the first trading day of next year.
Institutions purchasing after the New Year's can hold until the end of March, and sell by then and never report ownership at all. They also can buy with the hope that before the end of the quarter NWBO will be selling at a price, and perhaps on an exchange, which permits them to hold the shares through the quarter.
It's hard to say if the MM's got their fill on Friday, or if this trading action will continue. I would hope that no one here is panicked into selling, I look at it as a buying opportunity. Personally I felt I had all I wanted, my account is already concentrated on NWBO, but if it goes any lower, I almost certainly will make it even more concentrated.
Gary
There were several other great posts in the last day, one mentioned the possible roll of the MM's in yesterday's trading. I would suspect that the MM's are shaking the trees by selling to drop the price, then swooping in and buying far more shares than they sold for cheap. Why such a behavior, because they're anticipating good news and most important, they know they'll have great demand from some of their Institutional customers beginning January 3rd, the first trading day of next year.
Institutions purchasing after the New Year's can hold until the end of March, and sell by then and never report ownership at all. They also can buy with the hope that before the end of the quarter NWBO will be selling at a price, and perhaps on an exchange, which permits them to hold the shares through the quarter.
It's hard to say if the MM's got their fill on Friday, or if this trading action will continue. I would hope that no one here is panicked into selling, I look at it as a buying opportunity. Personally I felt I had all I wanted, my account is already concentrated on NWBO, but if it goes any lower, I almost certainly will make it even more concentrated.
Gary
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
